Novel Benzamide-Based Histamine H3 Receptor Antagonists:
The Identification of Two Candidates for Clinical Development |
| |
| Authors: | Michael A. Letavic,Leah Aluisio,Richard Apodaca,Manoj Bajpai,Ann J. Barbier,Anne Bonneville,Pascal Bonaventure,Nicholas I. Carruthers,Christine Dugovic,Ian C. Fraser,Michelle L. Kramer,Brian Lord,Timothy W. Lovenberg,Lilian Y. Li,Kiev S. Ly,Heather Mcallister,Neelakandha S. Mani,Kirsten L. Morton,Anthony Ndifor,S. Diane Nepomuceno,Chennagiri
R. Pandit,Steven B. Sands,Chandra R. Shah,Jonathan E. Shelton,Sandra S. Snook,Devin
M. Swanson,Wei Xiao |
| |
| Affiliation: | Janssen Pharmaceutical Company,a division of Johnson & Johnson Pharmaceutical Research &Development L.L.C., 3210 Merryfield Row, San Diego, California 92121, United States |
| |
| Abstract: | | |
| Keywords: | Histamine H3 antagonists phenyl(piperazin-1-yl)methanones histamine |
|
|
